BioHaus does not claim that the specific combination of HBOT, TMS, and photobiomodulation has been validated as a combined protocol in large-scale clinical trials. That research is still emerging. What the existing literature does support is the underlying rationale for why these modalities are used together.
Emerging research increasingly suggests that oxygenation, neuroplasticity, inflammation management, cellular energy production, and sleep quality are interconnected systems — not isolated processes.
HBOT and the biological foundation
Research supports HBOT's role in increasing oxygen delivery, supporting mitochondrial function, reducing inflammation, and stimulating cellular repair — creating a physiological environment that may enhance the brain's capacity to respond to neurological interventions.
TMS and neuroplasticity
The published TMS literature supports its ability to modulate brain network activity and encourage neuroplastic changes. Research suggests neuroplasticity is more readily supported when the brain has adequate oxygen and reduced inflammatory burden — conditions HBOT is designed to support.
Photobiomodulation and sustained recovery
PBM research supports its role in mitochondrial energy production and inflammation management between sessions — helping sustain the conditions for recovery rather than allowing them to fade.
The BioHaus Protocol is not based on a single study. It is informed by a body of evidence across multiple disciplines — and guided by the principle that the brain and body recover better when supported together.